Polymyositis occurring during α-interferon treatment for malignant melanoma: A case report and review of the literature

Rheumatology International

Volumn 19, Issue 1-2, 1999, Pages 65-67

  Cirigliano, G ^a   Della Rossa, A ^a   Tavoni, A ^a,b   Viacava, P ^a   Bombardieri, S ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UO Immuno Allergologia Clihica   (Italy)

Author keywords

Malignant melanoma; Polymyositis; interferon

Indexed keywords

PARACETAMOL; RECOMBINANT ALPHA2A INTERFERON;

ADULT; ARTICLE; CASE REPORT; FEMALE; HUMAN; MELANOMA; MUSCLE WEAKNESS; POLYMYOSITIS; PRIORITY JOURNAL;

EID: 0033385857     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002960050103     Document Type: Article

References (11)

1. Wortmann RL (1996) Inflammatory diseases of muscles and other myopathies. In: Kelley WN, Harris ED Jr, Ruddy S, Sledge CB (eds) Textbook of rheumatology, 5th edn. Saunders, Philadelphia
2. Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344-347
3. Einhorn S, Strander H (1993) Interferon treatment of human malignancies. A short review. Med Oncol Tumor Pharmacother 10:25-29
4. Johnson HM, Buzzer FV, Szente BE, Jarpe MA (1994) How interferons fight disease. Sci Am 270:68-75
5. Rusciani L, Petraglia S, Alotto M, Calvieri S, Vezzoni G (1997) Post-surgical adjuvant therapy for melanoma. Evaluation of a 3-year randomised trial with recombinant interferon-alpha after 3 and 5 years of follow-up. Cancer 79:2354-2360
6. Kalkner KM, Ronnblom L, Karlsson Parra A, Bengtsson M, Olsson Y, Oberg K (1998) Antibodies against double-stranded DNA and the development of polymyositis during treatment with interferon. Q J Med 91:393-399
7. Okanoue T, Sakamoto S, Itoh Y, Minami M, Yasui K, Sakamoto M, Nishioji K, Katagishi T, Nakagawa Y, Tada H, Sawa Y, Mizuno M, Kagawa K, Kashima K (1996) Side effects of high dose interferon therapy for chronic hepatitis C. J Hepatol 25:283-291
8. Rivers JK, Shaw HM, Milton GW, McCarthy WH (1990) Polymyositis in association with melanoma. Arch Dermatol 126:686-687
9. Lersch C, Fuchs R, Frank H, Schepp W (1995) Dermatomyositis as a complication of a metastatic melanoma: case report and a review of the literature. Immun Infekt 23:23-24
10. Matsuya M, Abe T, Tosaka M, Yonezawa K, Ono A, Ikeda N, Yoshida Y, Akahonai Y, Kurokawa S, Hayashi T et al (1994) The first case of polymyositis associated with interferon therapy. Intern Med 33:806-808
11. Iguchi H, Kishi M, Fujioka T, Wakata N, Kinoshita M (1996) Polymyositis after interferon beta treatment of chronic hepatitis type C. Rinsho Shinkeigaku 36:22-24